Seoul, South Korea

Soo Gyeong Ha


 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Soo Gyeong Ha

Introduction

Soo Gyeong Ha is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel peptides with anti-inflammatory properties. His work has the potential to impact various health-related applications.

Latest Patents

Soo Gyeong Ha holds a patent for "Peptides and use thereof." This invention focuses on novel peptides that exhibit anti-inflammatory effects. The patent encompasses a polynucleotide encoding the peptide, a pharmaceutical composition for preventing or treating inflammatory diseases, and various applications including over-the-counter drug compositions and health food formulations aimed at alleviating inflammation. Additionally, it outlines methods for treating inflammatory diseases and preparing mimetics of the peptide.

Career Highlights

Throughout his career, Soo Gyeong Ha has worked with reputable organizations such as Samsung Life Public Welfare Foundation and Il-yang Pharm Co., Ltd. His experience in these companies has contributed to his expertise in the pharmaceutical industry and innovation in peptide research.

Collaborations

Soo Gyeong Ha has collaborated with notable colleagues, including Dae Ho Cho and Min Kyung Jung. These partnerships have likely enhanced his research and development efforts in the field of anti-inflammatory treatments.

Conclusion

Soo Gyeong Ha's innovative work in peptide research and his contributions to pharmaceutical applications highlight his role as a significant inventor in the industry. His patent for anti-inflammatory peptides showcases the potential for advancements in treating inflammatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…